Selected Readings
We include these resources for your information, but did not create and do not endorse the content. We encourage you to please bring any questions or concerns to your provider.
- Hasler F, Grimberg U, Benz MA, Huber T, Vollenweider FX (2004) Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose-effect study. Psychopharmacology (Berl) 172: 145-56 (PDF)
- Human Hallucinogenic Research: Guidelines for Safety. Johnson, Richards, Griffiths (2008). Journal of Psychopharmacology.
- A review of the clinical effects of psychotomimetic agents. Osmond (1957). Annals of the New York Academy of Sciences.
- The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future. Carhart-Harris and Goodwin (2017). Neuropsychopharmacology.
- Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA. Mithoefer et al (2016). The Lancet Psychiatry.
- Heifets B, Malenk R (2016) MDMA as a Probe and Treatment for Social Behaviors. Cell 166: 269-272
- Mithoefer M, Grob C, Brewerton T (2016) Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA. The Lancet Psychiatry 3 (5): 481–488
- How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence. Michael Pollan